130 related articles for article (PubMed ID: 6583320)
1. Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone, and vincristine.
Pui CH; Jackson CW; Chesney C; Lyles SA; Bowman WP; Abromowitch M; Simone JV
J Clin Oncol; 1983 Jun; 1(6):380-5. PubMed ID: 6583320
[TBL] [Abstract][Full Text] [Related]
2. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
Priest JR; Ramsay NK; Bennett AJ; Krivit W; Edson JR
J Pediatr; 1982 Jun; 100(6):990-5. PubMed ID: 6953222
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
Miniero R; Pastore G; Saracco P; Messina M; Lange MM; Fiandino G; Iannacci L; Madon E
Am J Pediatr Hematol Oncol; 1986; 8(2):116-20. PubMed ID: 3461716
[TBL] [Abstract][Full Text] [Related]
4. Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia.
Pui CH; Chesney CM; Weed J; Jackson CW
J Clin Oncol; 1985 Sep; 3(9):1266-72. PubMed ID: 3875694
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
6. The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia.
Ramsay NK; Coccia PF; Krivit W; Nesbit ME; Edson JR
Cancer; 1977 Oct; 40(4):1398-401. PubMed ID: 269003
[TBL] [Abstract][Full Text] [Related]
7. Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy.
Shapiro RS; Gerrard JM; Ramsay NK; Nesbit ME; Coccia PF; Stoddard SF; Plow EF; White JG; Krivit W
Am J Pediatr Hematol Oncol; 1980; 2(3):207-12. PubMed ID: 6933865
[TBL] [Abstract][Full Text] [Related]
8. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632
[TBL] [Abstract][Full Text] [Related]
9. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; Rammeloo JA; de Koning J; van Zanen GE
Tijdschr Kindergeneeskd; 1988 Apr; 56(2):61-6. PubMed ID: 3287685
[TBL] [Abstract][Full Text] [Related]
10. Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia.
Homans AC; Rybak ME; Baglini RL; Tiarks C; Steiner ME; Forman EN
J Clin Oncol; 1987 May; 5(5):811-7. PubMed ID: 3572467
[TBL] [Abstract][Full Text] [Related]
11. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
12. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
[TBL] [Abstract][Full Text] [Related]
13. Vincristine and prednisone vs vincristine, L-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children.
Herson J; Starling KA; Dyment PG; Humphrey GB; Pullen J; Vats T
Med Pediatr Oncol; 1979; 6(4):317-23. PubMed ID: 384187
[TBL] [Abstract][Full Text] [Related]
14. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
[TBL] [Abstract][Full Text] [Related]
15. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
Aur RJ; Simone JV; Pratt CB
Cancer; 1971 Jun; 27(6):1332-6. PubMed ID: 5282619
[No Abstract] [Full Text] [Related]
16. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
[TBL] [Abstract][Full Text] [Related]
17. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
Appel IM; Hop WC; Pieters R
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
[TBL] [Abstract][Full Text] [Related]
18. Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia.
Pui CH; Jackson CW; Chesney CM; Abildgaard CF
Am J Hematol; 1987 Jul; 25(3):291-8. PubMed ID: 3111251
[TBL] [Abstract][Full Text] [Related]
19. Clotting complications of L-asparaginase therapy in children with ALL.
Cappellato MG; Rosolen A; Zanesco L; Girolami A
Blut; 1986 Jun; 52(6):377-8. PubMed ID: 3459563
[No Abstract] [Full Text] [Related]
20. Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia.
Cairo MS; Lazarus K; Gilmore RL; Baehner RL
J Pediatr; 1980 Nov; 97(5):829-33. PubMed ID: 6933231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
